tradingkey.logo

SNWV

SNWV
View Detailed Chart
25.830USD
+0.270+1.06%
Close 02/06, 16:00ETQuotes delayed by 15 min
221.52MMarket Cap
LossP/E TTM

SNWV

25.830
+0.270+1.06%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.06%

5 Days

-4.19%

1 Month

-14.86%

6 Months

-26.68%

Year to Date

-13.44%

1 Year

0.00%

View Detailed Chart

TradingKey Stock Score of SNWV

Currency: USD Updated: 2026-02-06

Key Insights

SANUWAVE Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 88 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 54.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SNWV's Score

Industry at a Glance

Industry Ranking
88 / 205
Overall Ranking
237 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

SNWV Highlights

StrengthsRisks
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 94.92% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.63M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 32.63M.
Undervalued
The company’s latest PE is -49.97, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.37M shares, decreasing 11.47% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 445.21K shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
54.000
Target Price
+111.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SNWV News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

SNWV Info

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
Ticker SymbolSNWV
CompanySANUWAVE Health Inc
CEOFrank (Morgan C)
Websitehttps://sanuwave.com/
KeyAI